John Gawain Elvin

This inventor holds 8 USPTO granted patents and 5 published patent applications, plus 1 CIPO patent and 2 EPO patents. Top assignees: Abbott Gmbh & Co Kg, Medimmune Limited, University of Cambridge. Active years: 2005-2018.

IDiyas Innovation Intelligence. (2026). Inventor Profile: John Gawain Elvin. Retrieved from https://idiyas.com/inventor/john-gawain-elvin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8 (Patent Applications = 5)

% Patents Active = 25.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 2

Average Co-Inventor Count = 11.9

ph-index = 3

Forward Citations = 418(Granted Patents)

Location History:

Meldreth, GB (2011)
Royston, GB (2014 - 2015)
Cambridge, GB (2005 - 2018)

Company Filing History:

University of Cambridge

patents

4. 1 out of 167

Abbvie Deutschland Gmbh and Co Kg

where one patent can have more than one assignee

Years Active: 2005-2018

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 9994636 - Anti-Siglec-15 antibodies and uses thereof (2018-06-12),

2. 9447192 - Anti-Siglec-15 antibodies and uses thereof (2016-09-20),

3. 9035030 - Human antibodies that bind the P40 subunit of human IL-12 and methods for using the same (2015-05-19),

4. 8865174 - Methods of treatment using human antibodies that bind IL-12 (2014-10-21),

5. 8765918 - Human antibodies that bind human interleukin-12 (2014-07-01),

6. 7883704 - Methods for inhibiting the activity of the P40 subunit of human IL-12 (2011-02-08),

7. 7504485 - Human antibodies that bind human IL-12 (2009-03-17),

8. 6914128 - Human antibodies that bind human IL-12 and methods for producing (2005-07-05),

Title: John Gawain Elvin: A Visionary Inventor Shaping the Future

Introduction:

John Gawain Elvin is a remarkable inventor whose dedication to innovation is shaping a better future. Hailing from Royston, GB, he has made significant contributions to the field of healthcare through his visionary ideas and patented inventions.

Latest Patents:

With a total of 8 patents to his name, John Gawain Elvin's latest breakthrough includes the development of Anti-Siglec-15 antibodies and their uses in the treatment of leukaemia, particularly acute myeloid leukaemia. This innovative approach holds promise for improving the lives of patients battling this challenging disease.

Career Highlights:

Throughout his career, John Gawain Elvin has worked with reputable companies such as Abbott GmbH & Co. Kg and Medimmune Limited. His expertise and passion for innovation have been instrumental in driving groundbreaking research and development projects in the healthcare sector.

Collaborations:

Collaborating with esteemed colleagues like Jochen G Salfeld and Michael Roguska, John Gawain Elvin has consistently pushed the boundaries of invention and technology. Together, they have worked on cutting-edge projects that have the potential to revolutionize healthcare and make a lasting impact on society.

Conclusion:

John Gawain Elvin's pioneering spirit and commitment to creating positive change through innovation continue to inspire the next generation of inventors. His visionary ideas and patented inventions stand as a testament to his unwavering dedication to improving the world we live in.

Profile summary based on public USPTO records.